Work

Transparent Implementation and Benchmarking of ACMG/AMP Variant Classification in fastVEP

Year: 2026
Type: preprint
Abstract: Background: The ACMG/AMP framework is the standard for germline sequence variant interpretation, but applying it in scalable automated software requires operational choices that the original framework and later ClinGen guidance do not always specify. We implemented an ACMG/AMP classification engine within fastVEP and evaluated which implementation choices improved agreement with expert-curated classifications without increasing concerning opposite-direction calls. Methods: The classifier implements all 28 ACMG/AMP criteria and can evaluate 15 from a sites-only VCF using nine public evidence sources. For selecting the optimal classifier, we compared symmetric and hybrid evidence-combining schemes, pathogenic class cutoffs, population-frequency thresholds, and benign-evidence thresholds against 673,660 ClinVar variants with review status of two stars or higher from April 2026. Clinical geneticists reviewed opposite-direction calls. We then applied the selected final classifier unchanged to 116,078 variants that newly reached the two-star threshold in the October 2026 ClinVar release. Results: The final fastVEP ACMG/AMP classifier uses the Tavtigian point scale on the pathogenic side and the 2015 ACMG/AMP combining table on the benign side. Using the 2015 table on both sides reduced pathogenic-side recall from 62.5 to 57.1 percent and lost 4,900 same-direction calls while avoiding 10 opposite-direction pathogenic calls. Using points on both sides increased benign-side recall from 66.4 to 77.0 percent, but increased opposite-direction benign calls from 27 to 399 and reduced recall of ClinVar uncertain variants from 97.1 to 69.5 percent. The 6-point Likely pathogenic cutoff was retained because lowering it to 5 points increased pathogenic-side recall to 73.9 percent but also classified 6,003 additional ClinVar uncertain variants and 17 additional ClinVar benign-side variants as pathogenic-side. The final classifier reproduced ClinVar's exact five-tier class for 431,727 variants or 64.1 percent and its pathogenic, benign, or uncertain direction for 534,335 variants or 79.3 percent. Only 51 calls or 0.0076 percent were opposite in direction to ClinVar. On the later variants, same-direction agreement was 72.6 percent and 20 calls were opposite in direction. Conclusions: The rules used to combine evidence affected classification more than several individual numeric thresholds. The hybrid scheme increased pathogenic-side recall while preventing a single Supporting benign criterion from producing a directional call. This conservative operating profile is suited to large-scale variant triage because it makes high-confidence calls while leaving variants uncertain when the available evidence does not support expert-level resolution. fastVEP is a research and decision-support tool and does not replace case-specific expert review.
Source: medRxiv
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W7236207359
Cites: 20
Cited by:
Related to: 10